Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Impact of adipose tissue on prostate cancer aggressiveness - analysis of a high-risk population.

Delouya G, Tiberi D, Bhatnagar SR, Campeau S, Saad F, Taussky D.

Horm Mol Biol Clin Investig. 2018 Nov 24. pii: /j/hmbci.ahead-of-print/hmbci-2018-0049/hmbci-2018-0049.xml. doi: 10.1515/hmbci-2018-0049. [Epub ahead of print]

PMID:
30471220
2.

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman LJ.

Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30411-9. doi: 10.1016/S2213-2600(18)30411-9. [Epub ahead of print]

PMID:
30442588
3.

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.

Preisser F, Mazzone E, Nazzani S, Marchioni M, Bandini M, Tian Z, Saad F, Soulières D, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Br J Cancer. 2018 Nov 14. doi: 10.1038/s41416-018-0323-3. [Epub ahead of print]

PMID:
30425350
4.

Prognostic value of progesterone receptor expression in tubo-ovarian high-grade serous carcinoma of the coeur cohort.

Le Page C, Rahimi K, Mes-Masson AM, Köbel M.

Histopathology. 2018 Nov 7. doi: 10.1111/his.13784. [Epub ahead of print]

PMID:
30403298
5.

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.

Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB; Cancer Genome Atlas Research Network, Camargo F, Liang H.

Cell Rep. 2018 Oct 30;25(5):1304-1317.e5. doi: 10.1016/j.celrep.2018.10.001.

6.

Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer.

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Tian Z, Saad F, Montorsi F, Zorn KC, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Oct 4. pii: S1558-7673(18)30581-0. doi: 10.1016/j.clgc.2018.09.024. [Epub ahead of print]

PMID:
30366880
7.

Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.

Bandini M, Nazzani S, Marchioni M, Preisser F, Tian Z, Moschini M, Abdollah F, Suardi N, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Sep 22. pii: S1558-7673(18)30185-X. doi: 10.1016/j.clgc.2018.09.011. [Epub ahead of print]

PMID:
30342845
8.

The intimate relationship between gut microbiota and cancer immunotherapy.

Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B.

Gut Microbes. 2018 Oct 19:1-5. doi: 10.1080/19490976.2018.1527167. [Epub ahead of print]

PMID:
30339501
9.

Tout le poids d'un nom, ou faut-il renommer notre spécialité?

Saad F.

Can Urol Assoc J. 2018 Oct;12(10):E428. doi: 10.5489/cuaj.5657. No abstract available.

10.

What's in a name? Renaming our specialty?

Saad F.

Can Urol Assoc J. 2018 Oct;12(10):298. doi: 10.5489/cuaj.5642. No abstract available.

11.

The effect of race on survival after local therapy in metastatic prostate cancer patients.

Mazzone E, Bandini M, Preisser F, Nazzani S, Tian Z, Abdollah F, Soulieres D, Graefen M, Montorsi F, Shariat S, Saad F, Briganti A, Karakiewicz P.

Can Urol Assoc J. 2018 Oct 15. doi: 10.5489/cuaj.5399. [Epub ahead of print]

PMID:
30332592
12.

Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.

Targeted Alpha Therapy Working Group, Parker C, Lewington V, Shore N, Kratochwil C, Levy M, Lindén O, Noordzij W, Park J, Saad F.

JAMA Oncol. 2018 Sep 20. doi: 10.1001/jamaoncol.2018.4044. [Epub ahead of print]

PMID:
30326033
13.

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet JD, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagné A, Hamel MA, Guimaraes CF, Coudert B, Arnould L, Favier L, Lagrange A, Ladoire S, Saintigny P, Ortiz-Cuaran S, Perol M, Foucher P, Hofman P, Ilie M, Chevrier S, Boidot R, Derangere V, Ghiringhelli F.

Br J Cancer. 2018 Oct;119(8):950-960. doi: 10.1038/s41416-018-0220-9. Epub 2018 Oct 15.

PMID:
30318514
14.

Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States.

Preisser F, Nazzani S, Mazzone E, Knipper S, Bandini M, Tian Z, Haese A, Saad F, Zorn KC, Montorsi F, Shariat SF, Graefen M, Tilki D, Karakiewicz PI.

World J Urol. 2018 Oct 12. doi: 10.1007/s00345-018-2525-y. [Epub ahead of print]

PMID:
30315358
15.

Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer.

Sharma NV, Pellegrini KL, Ouellet V, Giuste FO, Ramalingam S, Watanabe K, Adam-Granger E, Fossouo L, You S, Freeman MR, Vertino P, Conneely K, Osunkoya AO, Trudel D, Mes-Masson AM, Petros JA, Saad F, Moreno CS.

Cancers (Basel). 2018 Oct 11;10(10). pii: E379. doi: 10.3390/cancers10100379.

16.

Acute Kidney Injury Due to Inferior Vena Cava Stenosis After Liver Transplantation: A Case Report About the Importance of Hepatic Vein Doppler Ultrasound and Clinical Assessment.

Beaubien-Souligny W, Pépin MN, Legault L, Cailhier JF, Éthier J, Bouchard L, Willems B, Denault AY.

Can J Kidney Health Dis. 2018 Oct 3;5:2054358118801012. doi: 10.1177/2054358118801012. eCollection 2018.

17.

Expression of AR-V7 and ARv567es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGY.

Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Kim S, Worroll D, Stewart J, Zaher A, Szatrowski TP, Ballman KV, Kita K, Tasaki S, Bai Y, Portella L, Kirby BJ, Saad F, Eisenberger MA, Nanus DM, Giannakakou P.

Clin Cancer Res. 2018 Oct 9. pii: clincanres.0320.2018. doi: 10.1158/1078-0432.CCR-18-0320. [Epub ahead of print]

PMID:
30301829
18.

Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

World J Urol. 2018 Oct 8. doi: 10.1007/s00345-018-2516-z. [Epub ahead of print]

PMID:
30298285
19.

Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

Bear HD, Wan W, Robidoux A, Rubin P, Limentani S, White RL Jr, Granfortuna J, Hopkins JO, Oldham D, Rodriguez A, Sing AP.

J Surg Oncol. 2018 Sep;118(4):722. doi: 10.1002/jso.24798. Epub 2017 Jul 28. No abstract available.

PMID:
30295942
20.

Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer.

Tosco L, Briganti A, D'amico AV, Eastham J, Eisenberger M, Gleave M, Haustermans K, Logothetis CJ, Saad F, Sweeney C, Taplin ME, Fizazi K.

Eur Urol. 2018 Oct 1. pii: S0302-2838(18)30549-9. doi: 10.1016/j.eururo.2018.07.027. [Epub ahead of print] Review.

PMID:
30286948

Supplemental Content

Loading ...
Support Center